The gene therapy industry is becoming increasingly important as biopharmaceutical companies and healthcare systems focus on durable, potentially curative treatment options for genetically driven diseases. These therapies support demanding applications across rare monogenic disorders, inherited retinal diseases, hemophilia, and select oncology indications. The growing emphasis on vector...